Lemaitre Vascular (NASDAQ:LMAT) reported Q2 EPS of $0.29, $0.04 better than the analyst estimate of $0.25. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $41.39 million.
Lemaitre Vascular (NASDAQ:LMAT) reported Q2 EPS of $0.29, $0.04 better than the analyst estimate of $0.25. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $41.39 million.